Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide costs vary depending on the dose, the provider, and exactly what that price covers. In the UK private market, monthly costs for Wegovy (the semaglutide brand licensed for weight management) have typically ranged from around £149 to over £300, shifting higher since Eli Lilly's competitor tirzepatide repriced its own product upward in late 2025. These are prescription-only medicines — a qualified prescriber must assess you before any semaglutide is dispensed, regardless of where you buy. At nume, that clinical assessment is included in one transparent price, alongside your prescription, treatment, and free next-working-day delivery.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you search for semaglutide costs in the UK, find a number that looks manageable, and click through. Then, partway through checkout, a consultation fee appears. Or a prescription charge. Or a delivery cost for a cold-chain medicine that needs tracking. By the time you reach the payment screen, the actual monthly outlay looks quite different from the headline.
This is a question our prescribers hear most weeks, not just about semaglutide cost in the UK, but about why identical-looking prices from different providers turn out not to be identical at all. The short answer: some providers itemise separately. Consultation, clinical review, the prescription itself, delivery, and any follow-up support can all carry their own charge. A low starting figure sometimes covers the pen and nothing else.
There is also the question of dose. Wegovy's titration schedule moves from 0.25mg upward through several steps to a maintenance dose; the pens at different stages carry different costs. A quoted price at the starter dose will not reflect what you pay once you reach the dose at which most people see meaningful results. The actual monthly cost of Wegovy depends on where you are in that schedule, and it is worth understanding the full picture before you commit.
Semaglutide is also available as a daily tablet, Wegovy tablets, the first oral GLP-1 medicine licensed for weight management in the UK, approved by the MHRA in June 2026. Pricing for the tablet form sits within the same private market, and the same rule applies: check what the stated price actually includes. More on how Wegovy works, in both forms, is on our treatment overview page.
Semaglutide (Wegovy) is a Prescription-Only Medicine. That legal classification exists because the risks, contraindications, and dosing decisions for this medicine require clinical judgement. NICE's appraisal of semaglutide for weight management and NHS guidance on semaglutide both make clear that this is a medicine prescribed within a framework of monitoring and review, not a product you assess yourself by reading a label.
Price is the wrong test for a prescription medicine. The right questions are: is the pharmacy GPhC-registered and verifiable on the GPhC register? Is there a named prescriber reviewing your case, not an algorithm? Is the medicine sourced through the licensed UK supply chain? The MHRA has warned publicly about counterfeit weight-loss pens sold online, some containing insulin rather than the stated medicine. A saving of £20 on a fake pen is not a saving.
None of this means expensive is automatically better. It means that clinical legitimacy (a real prescription from a real prescriber, genuine medicine from a regulated pharmacy) is the baseline, and price comparisons only make sense once that baseline is confirmed. A fuller breakdown of semaglutide costs and what drives them covers this in more detail.
We are not the cheapest provider of semaglutide in the UK. That is a deliberate position. Our single price covers the consultation, the prescription, the treatment itself, free tracked delivery the next working day, and seven-day aftercare with clinical re-review before every repeat. There is no subscription and no auto-renewal. Every order is assessed on its own terms by a GPhC-registered Independent Prescriber.
We do not run discount codes, voucher promotions, or seasonal offers on prescription medicines. Beyond the compliance reasons, discounting a POM sends the wrong signal about how the medicine should be treated. What we do offer is transparency: the price you see on our treatment page is the price you pay, with everything included.
If the monthly figure for semaglutide feels significant, it is worth thinking about it as the cost of clinically supervised, genuine, tracked treatment, not just the cost of a pen. For anyone weighing up the ongoing outlay, a month-by-month view of semaglutide costs may help clarify what you're actually budgeting for over time. If you are also preparing to use your treatment at home, our guidance on how much sterile water to use when reconstituting 5mg semaglutide walks through the process clearly. And for a side-by-side comparison with tirzepatide pricing, our Wegovy pricing page sets out the relevant context.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.